[go: up one dir, main page]

AU4431400A - Anticancer agents containing ep1 antagonists as the active ingredient - Google Patents

Anticancer agents containing ep1 antagonists as the active ingredient

Info

Publication number
AU4431400A
AU4431400A AU44314/00A AU4431400A AU4431400A AU 4431400 A AU4431400 A AU 4431400A AU 44314/00 A AU44314/00 A AU 44314/00A AU 4431400 A AU4431400 A AU 4431400A AU 4431400 A AU4431400 A AU 4431400A
Authority
AU
Australia
Prior art keywords
antagonists
active ingredient
anticancer agents
agents containing
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44314/00A
Inventor
Takayuki Maruyama
Keiji Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORGANIZATION FOR PHARMACEUTICAL SAFETY AND RESEARCH
Ono Pharmaceutical Co Ltd
National Cancer Center Japan
Original Assignee
JAPAN GOVERNMENT
ORGANIZATION FOR PHARMACEUTICA
Ono Pharmaceutical Co Ltd
National Cancer Center Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN GOVERNMENT, ORGANIZATION FOR PHARMACEUTICA, Ono Pharmaceutical Co Ltd, National Cancer Center Japan filed Critical JAPAN GOVERNMENT
Publication of AU4431400A publication Critical patent/AU4431400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU44314/00A 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient Abandoned AU4431400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13119599 1999-05-12
JP11/131195 1999-05-12
PCT/JP2000/003028 WO2000069465A1 (en) 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient

Publications (1)

Publication Number Publication Date
AU4431400A true AU4431400A (en) 2000-12-05

Family

ID=15052259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44314/00A Abandoned AU4431400A (en) 1999-05-12 2000-05-11 Anticancer agents containing ep1 antagonists as the active ingredient

Country Status (2)

Country Link
AU (1) AU4431400A (en)
WO (1) WO2000069465A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230056B1 (en) * 2001-03-12 2015-06-29 Ono Pharmaceutical Co., Ltd N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
SE0100873D0 (en) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
EP1369129A4 (en) * 2001-03-14 2005-08-03 Ono Pharmaceutical Co Remedies for depression containing ep1 antagonist as the active ingredient
DE10121003A1 (en) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
GB0114004D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0114005D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
TW200817319A (en) 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
ES2437323T3 (en) 2007-02-16 2014-01-10 Ono Pharmaceutical Co., Ltd. Therapeutic agent for urination disorders
EP2305304A4 (en) 2008-04-28 2011-08-10 Nat University Corp Hamamatsu University School Of Medicine IMMUNOSTIMULANT COMPRISING THE EP1 AGONIST
KR20110027648A (en) 2008-06-23 2011-03-16 아스테라스 세이야쿠 가부시키가이샤 Sulfonamide compounds or salts thereof
CN102089303A (en) 2008-07-17 2011-06-08 旭化成制药株式会社 Nitrogenated heterocyclic compound
WO2010007944A1 (en) 2008-07-17 2010-01-21 旭化成ファーマ株式会社 Nitrogenated bicyclic heterocyclic compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570594B1 (en) * 1991-12-10 1997-07-30 Shionogi & Co., Ltd. Hydroxamic acid derivative based on aromatic sulfonamide

Also Published As

Publication number Publication date
WO2000069465A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
IL157940A0 (en) Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient
AU2006601A (en) Medicament dispenser
AU2509901A (en) Medicament dispenser
AU1690399A (en) Neovascularization inhibitor containing dienogest as the active ingredient
AU3192700A (en) Medicinal compositions
AU6795600A (en) Gums containing antimicrobial agents
AU1514401A (en) Medicament dispenser
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU4431400A (en) Anticancer agents containing ep1 antagonists as the active ingredient
AU6460400A (en) Pharmaceutical compositions
AU5786300A (en) Muscarinic antagonists
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU6460200A (en) Pharmaceutical compositions
AU2023801A (en) Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient
AU5809400A (en) Fungicidal compositions
AU9462498A (en) Hysteromyoma remedy containing dienogest as the active ingredient
AU6325200A (en) Stable biocidal compositions
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
AU1530601A (en) Biocide compositions
ZA200109902B (en) Stable biocidal compositions.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase